– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials
– This next-generation anthracycline demonstrates safety and promising early activity in treating multiple oncology indications
HOUSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), announced it has received a new independent assessment for the absence of cardiotoxicity in subjects treated with Annamycin, bringing the total number of Annamycin treated subjects reviewed by its independent expert to 90. Data from the most recently completed clinical trials’ subjects were made available to an expert in chemotherapy who is affiliated with a leading cancer research institute in assessing cardiotoxicity. After review of certain data, the independent expert concluded that there was...
Nukkleus Inc. Completes Strategic Acquisition of Star 26 Capital, Expanding Defense AI and Defense Manufacturing
Written by Customer Service on . Posted in Mergers And Acquisitions.
Deal adds precision manufacturing, advanced computer vision, and other defense technology businesses into the Nukkleus ecosystem
NEW YORK and TEL AVIV, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK), a strategic acquirer and owner of high-potential businesses in the aerospace and defense (A&D) industry, today announced the successful completion of its acquisition of Star 26 Capital Inc., a defense-focused acquisition company.
Nukkleus acquired 100% of Star 26 in consideration of a mixed package of cash, promissory notes, as well as shares of Nukkleus common stock and associated warrants issued to Star 26 shareholders on a pro-rata basis. Additional details regarding the transaction are available in the Company’s filings with the Securities and Exchange Commission.
The transaction provides Nukkleus with...
Skyward Group Leverages Apollo Acquisition to Expand Skyward Specialty’s Life Sciences Solution Globally
Written by Customer Service on . Posted in Mergers And Acquisitions.
HOUSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) — Skyward Group (Nasdaq: SKWD) (“the Group” or “the Company”), the unified specialty insurance organization whose operating businesses include Skyward Specialty and Apollo, today announced the global expansion of Skyward Specialty’s Life Sciences insurance solution. Through this expansion, and by leveraging Apollo’s Lloyd’s Syndicate 1969, Skyward Specialty now offers enhanced multinational placements for U.S.-domiciled life sciences companies with international operations. This initiative marks the first strategic collaboration between Skyward Specialty and Apollo since the acquisition closed earlier this month.
Skyward Group Chairman and Chief Executive Officer Andrew Robinson said, “The expansion of our Life Sciences product reflects the strength of our combined organization and our ability...
SEALSQ Announces FY 2025 Preliminary Unaudited Key Operational and Financial Metrics
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Geneva, Switzerland, Jan. 13, 2026 (GLOBE NEWSWIRE) —
Strong Balance Sheet With Over $425 Million in Cash Supports Global Quantum Ecosystem Expansion; $200 Million Pipeline Over the Next Three Years Supports Long-Term Growth
SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a leader in Semiconductors, PKI, and Post-Quantum technology today announced full-year (FY) 2025 key operational and financial metrics (all financial data are preliminary and unaudited).
FY 2025 Revenue and Financial Highlights:+66% year on year revenue growth: Preliminary unaudited 2025 revenue of $18 million, with $8 million recorded in the fourth quarter of the year, compared to $4 million in the equivalent period last year.
Growth drivers: The growth was driven primarily by renewed demand for traditional SEALSQ products and the consolidation of...
Propanc Biopharma Provides Shareholder Update
Written by Customer Service on . Posted in Public Companies.
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026
MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced a shareholder update from its Chief Executive Officer and Cofounder, Mr. James Nathanielsz.
In this update, Mr. Nathanielsz highlights the significant progress achieved during 2025 and outlines the Company’s ambitious plans for 2026. With strong confidence, Propanc is executing its strategic roadmap for the clinical development of its lead asset, PRP, while further strengthening its scientific platform by expanding into additional therapeutic areas with high unmet medical need...
iRocket and BPGC Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 with the SEC
Written by Customer Service on . Posted in Mergers And Acquisitions.
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — Innovative Rocket Technologies Inc. (“iRocket” or the “Company”) and BPGC Acquisition Corp. (“BPGC”) announced that, in connection with the previously disclosed proposed business combination, iRocket Technologies, Inc., a subsidiary of the Company (“Holdco”), has confidentially submitted a draft registration statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”).
The proposed business combination (the “Business Combination”) was initially announced on July 23, 2025. Subject to the completion of the SEC review process and satisfaction of customary closing conditions, including the approval of BPGC’s shareholders, Holdco is expected to be listed on Nasdaq under the ticker symbol “IRX” upon the closing of the transaction.
About iRocketiRocket, founded in 2018 and...
AITX Retains National PR Firm as Market Awareness Accelerates
Written by Customer Service on . Posted in Public Companies.
Company Aligns Communications Strategy with Growing Industry and Investor Interest
Detroit, Michigan, Jan. 13, 2026 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions, today announced that it has engaged a national public relations firm to expand awareness of the Company across the media, financial markets, and investor community. The engagement is intended to elevate understanding of AITX’s business model, technology leadership, and long term growth strategy as the Company enters its next phase of market visibility.
The decision follows a period of expanding operational scale, increased market relevance, and growing interest in the Company’s autonomous security and AI driven solutions. As AITX continues to execute...
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
Written by Customer Service on . Posted in Public Companies.
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation, AI and defense
Raanana, Israel, Jan. 13, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, recently announced that its Board of Directors has authorized the exploration of strategic investment opportunities in select revenue-generating assets.
Polyrizon is focusing its initial efforts on operating companies in high-potential sectors, including defense, aviation, and artificial intelligence (AI).
The Company remains fully committed to its core medical device activities, continuing to advance product development, preclinical and clinical studies,...
Old Glory Bank and Digital Asset Acquisition Corp. Announce Business Combination Agreement to Create a Texas Company Publicly Listed on Nasdaq
Written by Customer Service on . Posted in Mergers And Acquisitions.
“We intend for Old Glory Bank to be the first chartered bank to fully integrate crypto into daily banking.” Michael Staw, Co-Founder and Chief Innovation Officer.
Main Street, America, Jan. 13, 2026 (GLOBE NEWSWIRE) —
Old Glory Bank, serving customers in all 50 states with its pro-America online banking platform, and Digital Asset Acquisition Corporation (Nasdaq: DAAQ) (“DAAQ”), a special purpose acquisition company, today announced that DAAQ and Old Glory Bank’s Bank Holding Company have entered into a definitive business combination agreement to create OGB Financial Company, a Texas corporation to be listed on Nasdaq under the reserved ticker symbol “OGB.” The closing of the transaction is expected to occur at the end of the first quarter or early in the second quarter of 2026 and is subject to approval by the shareholders of...
Prosafe SE: Company Presentation
Written by Customer Service on . Posted in Public Companies.
Oslo, 13 January 2026: Prosafe SE (“Prosafe” or the “Company”) has today published a company presentation in connection with a non-deal roadshow in January. The presentation is attached and will also be made available on the Company’s webside www.prosafe.com.
For further information, please contact: Reese McNeel, CEO Phone: +47 415 08 186
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentProsafe Company Presentation January 2026 pdf
